PTC Therapeutics Inc. buy Wells Fargo & Company
Start price
27.05.25
/
50%
€41.80
Target price
27.05.26
€64.95
Performance (%)
-8.13%
Price
12.08.25
€36.40
Summary
This prediction is currently active. With a performance of -8.13%, the BUY prediction for PTC Therapeutics Inc. by Wells_Fargo___Compan is down slightly. This prediction currently runs until 27.05.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| PTC Therapeutics Inc. | -16.895% | -16.895% |
| iShares Core DAX® | 1.061% | -0.453% |
| iShares Nasdaq 100 | 2.615% | 4.747% |
| iShares Nikkei 225® | 5.693% | 9.002% |
| iShares S&P 500 | 1.433% | 3.156% |
Comments by Wells_Fargo___Compan for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at Wells Fargo & Company from $68.00 to $74.00. They now have an "overweight" rating on the stock.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€39.00
08.08.25
08.08.25
€67.74
08.08.26
08.08.26
-0.51%
12.08.25
12.08.25
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€43.60
29.07.25
29.07.25
€67.26
29.07.26
29.07.26
-11.01%
12.08.25
12.08.25
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€45.40
26.11.24
26.11.24
€64.72
26.11.25
26.11.25
-14.54%
12.08.25
12.08.25
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€24.20
08.12.23
08.12.23
€34.41
08.12.24
08.12.24
78.51%
09.12.24
09.12.24